The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients
The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients
About this item
Full title
Author / Creator
Publisher
Bristol: IOP Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Bristol: IOP Publishing
Subjects
More information
Scope and Contents
Contents
Background
. In recent years, greenhouse gas (GHG) emissions from inhalers have received more attention. The inhalers are classified as controllers and relievers, which are mainly short-acting beta-agonists (SABA), and SABAs account for more than 50% of all inhaler use in most countries. The overuse of SABA is common in asthma patients, but the...
Alternative Titles
Full title
The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_iop_journals_10_1088_2515_7620_ad9818
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_iop_journals_10_1088_2515_7620_ad9818
Other Identifiers
ISSN
2515-7620
E-ISSN
2515-7620
DOI
10.1088/2515-7620/ad9818